/ Strides Shasun Gets USFDA Nod For Memantine Hydrochloride Tablets ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 24 May 2017

Strides Shasun on Wednesday informed that it has received approval from the United States Food & Drug Administration (USFDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, as per BSE filing.

Memantine Hydrochloride Tablets are used for the treatment of moderate to severe Alzheimer- type dementia.

Strides Shasun is down by 3.4% at Rs 875.70 per share at 12:46 hours IST on BSE.  It hit a high of Rs 918.95 and a low of Rs 876.80 so far during the day.

The company’s peers include Lupin, Wockhardt and Laurus Labs.

On the NSE, the traded volume of shares of the company is 1,83,251 and the traded value is Rs 1647.24 lakhs. The free-float market capitalisation of the company is Rs 5596.04 crore.

Strides Shasun Limited is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717